Navigation Links
CryoCath to Hold First Quarter 2008 Conference Call and Webcast
Date:2/7/2008

http://www.cryocath.com Toronto Stock Exchange Symbol: CYT

MONTREAL, Feb. 7 /PRNewswire-FirstCall/ - CryoCath (TSX: CYT), will hold a conference call to discuss its first quarter 2008 financial results at 4:30 p.m. (Eastern Time) on Thursday, February 14, 2008. The Company will report its results in a press release to be issued at 4:00 p.m. on Thursday, February 14.

DATE: Thursday, February 14, 2008

TIME: 4:30 p.m., Eastern Standard Time

TAPED REPLAY: 416-640-1917 or 1-877-289-8525 (Available until

February 21, 2008)

REFERENCE NUMBER: 21262307

WEBCAST: A live audio webcast of the call will be available at

http://www.cryocath.com. Webcast attendees are welcome to

listen to the conference in real-time or on-demand at

their convenience. The webcast will be archived for

365 days. Please connect to this website at least

15 minutes prior to the conference call to ensure

adequate time for any software download that may be

needed to hear the webcast.

About CryoCath

CryoCath - http://www.cryocath.com - is a medical technology company that leads the world in cryotherapy products to treat cardiovascular disease. With a priority focus on providing physicians with a complete solution of catheter products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The Company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias.

This press release includes "forward-looking statements" that are subject to risks and uncertainties, including with respect to the timing of regulatory trials and their outcome. For information identifying legislative or regulatory, economic, climatic, currency, technological, competitive and other important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, see CryoCath's annual report available at http://www.sedar.com under the heading Risks and Uncertainties in the Management's Discussion and Analysis section.


'/>"/>
SOURCE CryoCath Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CryoCath intends to contest patent infringement claim by CryoCor, Inc.
2. CryoCath announces 2007 fourth quarter and fiscal year end financial results
3. CryoCath to present at Piper Jaffray and BMO Healthcare conferences
4. CryoCath to present at CIBC Healthcare Conference
5. CryoCath files patent infringement lawsuit
6. PetFirst: Pet Insurance To Be More Popular in 2008
7. Nile Therapeutics Announces Dosing of First Heart Failure Patient in Phase Ib Study of CD-NP
8. The Female Health Company Schedules First Quarter Conference Call for February 13, 2008
9. First 90 Days After Stopping Plavix Most Dangerous
10. R Baby Foundation Raises $2.5 Million in First Year
11. American Pacific to Release Financial Results and Hold Fiscal 2008 First Quarter Investor Teleconference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... Ellevate Network, the ... business to advocate for action towards gender equality at their inaugural Summit in New ... the globe, and reached a social audience of over 3 million. To watch the ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. ... big data solutions, today announced that its MyDario product is expected to ... TV listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
Breaking Medicine Technology: